Literature DB >> 9057778

Zileuton for asthma.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057778

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN: 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  4 in total

Review 1.  Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.

Authors:  Bhupendrasinh F Chauhan; Francine M Ducharme
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Leukotrienes in atherosclerosis: new target insights and future therapy perspectives.

Authors:  Graziano Riccioni; Alessandra Zanasi; Nicola Vitulano; Barbara Mancini; Nicolantonio D'Orazio
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

3.  Genome-wide association study of leukotriene modifier response in asthma.

Authors:  A Dahlin; A Litonjua; C G Irvin; S P Peters; J J Lima; M Kubo; M Tamari; K G Tantisira
Journal:  Pharmacogenomics J       Date:  2015-06-02       Impact factor: 3.550

4.  The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma.

Authors:  Amber Dahlin; Weiliang Qiu; Augusto A Litonjua; John J Lima; Mayumi Tamari; Michiaki Kubo; Charles G Irvin; Stephen P Peters; Ann C Wu; Scott T Weiss; Kelan G Tantisira
Journal:  Pharmacogenomics J       Date:  2018-01-03       Impact factor: 3.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.